COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$23.23
+1.00% today
Updated 2026-10-28
Market cap
$754.97M
P/E ratio
18.26
P/S ratio
0.93x
EPS (TTM)
$1.27
Dividend yield
—
52W range
$21 – $51
Volume
0.8M
Collegium Pharmaceutical Inc (COLL) Insider transactions
Net insider activity
Net buying (71,411 shares)
Buy transactions
39
Sell transactions
61
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | SANTINI, GINO | Director | Sale | 8,700 | — | — |
| 2026-06-08 | SANTINI, GINO | Director | Buy | 8,700 | $16.49 | $143463.00 |
| 2026-05-18 | FREUND, JOHN GORDON | Director | Sale | 20 | $34.05 | $681.00 |
| 2026-05-15 | FREUND, JOHN GORDON | Director | Sale | 8,700 | — | — |
| 2026-05-15 | FREUND, JOHN GORDON | Director | Buy | 8,700 | $16.49 | $143463.00 |
| 2026-05-15 | FREUND, JOHN GORDON | Director | Sale | 4,127 | $34.54 | $142546.58 |
| 2026-05-14 | SANTINI, GINO | Director | Buy | 8,741 | — | — |
| 2026-05-14 | PAYA, CARLOS V | Director | Buy | 8,741 | — | — |
| 2026-05-14 | LURKER, NANCY | Director | Buy | 8,741 | — | — |
| 2026-05-14 | GLANCY, DONOVAN MICHAEL | Director | Buy | 17,482 | — | — |
| 2026-05-14 | FREUND, JOHN GORDON | Director | Buy | 8,741 | — | — |
| 2026-05-14 | BOHLIN, GAREN G | Director | Buy | 8,741 | — | — |
| 2026-05-14 | BALICE-GORDON, RITA J. | Director | Buy | 8,741 | — | — |
| 2026-05-13 | LURKER, NANCY | Director | Sale | 4,500 | $35.97 | $161860.95 |
| 2026-05-11 | BOHLIN, GAREN G | Director | Sale | 8,700 | — | — |
| 2026-05-11 | BOHLIN, GAREN G | Director | Sale | 8,700 | $37.18 | $323491.23 |
| 2026-03-18 | DIETER, DAVID | EVP & General Counsel | Sale | 13,976 | $34.92 | $488099.22 |
| 2026-03-17 | DIETER, DAVID | EVP & General Counsel | Sale | 8,840 | $35.72 | $315764.80 |
| 2026-03-09 | DIETER, DAVID | EVP & General Counsel | Sale | 6,224 | $36.65 | $228109.60 |
| 2026-03-03 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 46,417 | $40.36 | $1.87M |
| 2026-03-03 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 3,559 | $40.99 | $145879.50 |
| 2026-02-10 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Buy | 32,734 | — | — |
| 2026-02-10 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 26,679 | $46.75 | $1.25M |
| 2026-02-10 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Buy | 26,421 | — | — |
| 2026-02-10 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 11,861 | $46.75 | $554501.75 |
| 2026-02-10 | SMITH, THOMAS B | EVP and Chief Medical Officer | Buy | 22,774 | — | — |
| 2026-02-10 | SMITH, THOMAS B | EVP and Chief Medical Officer | Buy | 14,268 | — | — |
| 2026-02-10 | SMITH, THOMAS B | EVP and Chief Medical Officer | Sale | 11,538 | $46.75 | $539401.50 |
| 2026-02-10 | SMITH, THOMAS B | EVP and Chief Medical Officer | Sale | 5,897 | $46.75 | $275684.75 |
| 2026-02-10 | KARNANI, VIKRAM | Director, President and CEO | Buy | 79,264 | — | — |
| 2026-02-10 | KARNANI, VIKRAM | Director, President and CEO | Buy | 32,531 | — | — |
| 2026-02-10 | KARNANI, VIKRAM | Director, President and CEO | Sale | 11,296 | $46.75 | $528088.00 |
| 2026-02-10 | DREYER, SCOTT | EVP & Chief Commercial Officer | Buy | 30,702 | — | — |
| 2026-02-10 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 21,615 | $46.75 | $1.01M |
| 2026-02-10 | DREYER, SCOTT | EVP & Chief Commercial Officer | Buy | 19,023 | — | — |
| 2026-02-10 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 9,977 | $46.75 | $466424.75 |
| 2026-02-10 | DIETER, DAVID | EVP & General Counsel | Buy | 22,194 | — | — |
| 2026-02-10 | DIETER, DAVID | EVP & General Counsel | Buy | 9,005 | — | — |
| 2026-02-10 | DIETER, DAVID | EVP & General Counsel | Sale | 2,781 | $46.75 | $130011.75 |
| 2025-12-08 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 17,600 | — | — |
| 2025-12-08 | DREYER, SCOTT | EVP & Chief Commercial Officer | Buy | 17,600 | $15.90 | $279840.00 |
| 2025-12-08 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 11,125 | $47.89 | $532770.69 |
| 2025-12-08 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 6,475 | $48.66 | $315084.51 |
| 2025-12-05 | BALICE-GORDON, RITA J. | Director | Sale | 3,650 | $47.03 | $171673.37 |
| 2025-11-12 | KARNANI, VIKRAM | Director, President and CEO | Sale | 8,983 | $47.35 | $425345.05 |
| 2025-11-12 | FALLON, JOHN A. | Director | Sale | 19,853 | — | — |
| 2025-11-12 | FALLON, JOHN A. | Director | Sale | 15,000 | — | — |
| 2025-11-12 | FALLON, JOHN A. | Director | Sale | 34,853 | $47.21 | $1.65M |
| 2025-11-12 | FALLON, JOHN A. | Director | Buy | 19,853 | $9.33 | $185228.49 |
| 2025-11-12 | FALLON, JOHN A. | Director | Buy | 15,000 | $16.49 | $247350.00 |
| 2025-11-06 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 25,142 | $40.38 | $1.02M |
| 2025-11-06 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 4,858 | $41.28 | $200516.86 |
| 2025-08-29 | SMITH, THOMAS B | EVP and Chief Medical Officer | Sale | 17,478 | $38.42 | $671576.42 |
| 2025-08-18 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 16,389 | — | — |
| 2025-08-18 | DREYER, SCOTT | EVP & Chief Commercial Officer | Buy | 16,389 | $21.34 | $349741.26 |
| 2025-08-15 | SANTINI, GINO | Director | Sale | 15,000 | — | — |
| 2025-08-15 | SANTINI, GINO | Director | Buy | 15,000 | $13.45 | $201750.00 |
| 2025-08-15 | SANTINI, GINO | Director | Sale | 5,405 | $37.19 | $201018.44 |
| 2025-08-13 | RUBRIC, CAPITAL MANAGEMENT LP | 10% Owner | Sale | 25,000 | $37.85 | $946250.00 |
| 2025-08-13 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 4,861 | — | — |
| 2025-08-13 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 4,861 | $38.03 | $184880.84 |
| 2025-08-08 | FREUND, JOHN GORDON | Director | Sale | 11,659 | $34.36 | $400640.55 |
| 2025-06-09 | FREUND, JOHN GORDON | Director | Sale | 15,000 | — | — |
| 2025-06-09 | FREUND, JOHN GORDON | Director | Buy | 15,000 | $13.45 | $201750.00 |
| 2025-06-09 | FREUND, JOHN GORDON | Director | Sale | 6,601 | $30.62 | $202149.02 |
| 2025-05-15 | SANTINI, GINO | Director | Buy | 9,791 | — | — |
| 2025-05-15 | PAYA, CARLOS V | Director | Buy | 19,582 | — | — |
| 2025-05-15 | LURKER, NANCY | Director | Buy | 9,791 | — | — |
| 2025-05-15 | FREUND, JOHN GORDON | Director | Buy | 9,791 | — | — |
| 2025-05-15 | FALLON, JOHN A. | Director | Buy | 9,791 | — | — |
| 2025-05-15 | BOHLIN, GAREN G | Director | Buy | 9,791 | — | — |
| 2025-05-15 | BALICE-GORDON, RITA J. | Director | Buy | 9,791 | — | — |
| 2025-03-21 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 6,396 | $30.03 | $192068.68 |
| 2025-03-21 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 18,881 | $30.03 | $566983.21 |
| 2025-03-20 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 1,206 | $30.00 | $36181.33 |
| 2025-03-20 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 1,927 | $30.00 | $57810.96 |
| 2025-03-17 | DIETER, DAVID | EVP & General Counsel | Buy | 68,449 | — | — |
| 2025-03-14 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 977 | $30.00 | $29313.32 |
| 2025-03-14 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 2,255 | $30.00 | $67661.05 |
| 2025-03-11 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 10,445 | $30.01 | $313412.67 |
| 2025-03-11 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 15,387 | $30.00 | $461671.55 |
| 2025-03-07 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 1,504 | $30.00 | $45121.05 |
| 2025-03-07 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 2,348 | $30.00 | $70445.87 |
| 2025-03-06 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 1,949 | $30.00 | $58470.00 |
| 2025-03-06 | KUHLMANN, SHIRLEY R. | EVP and General Counsel | Sale | 26,067 | $28.50 | $742945.99 |
| 2025-03-06 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 15,387 | $30.00 | $461671.55 |
| 2025-03-06 | DREYER, SCOTT | EVP & Chief Commercial Officer | Sale | 3,295 | $30.00 | $98853.62 |
| 2025-03-05 | KUHLMANN, SHIRLEY R. | EVP and General Counsel | Sale | 20,000 | $28.03 | $560528.00 |
| 2025-03-04 | KUHLMANN, SHIRLEY R. | EVP and General Counsel | Sale | 40,000 | — | — |
| 2025-03-04 | KUHLMANN, SHIRLEY R. | EVP and General Counsel | Sale | 40,000 | $28.08 | $1.12M |
| 2025-02-10 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Buy | 51,768 | — | — |
| 2025-02-10 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Buy | 26,957 | — | — |
| 2025-02-10 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 22,317 | $30.52 | $681114.84 |
| 2025-02-10 | TUPPER, COLLEEN | EVP & Chief Financial Officer | Sale | 8,109 | $30.52 | $247486.68 |
| 2025-02-10 | SMITH, THOMAS B | EVP and Chief Medical Officer | Buy | 33,762 | — | — |
| 2025-02-10 | SMITH, THOMAS B | EVP and Chief Medical Officer | Buy | 5,313 | — | — |
| 2025-02-10 | SMITH, THOMAS B | EVP and Chief Medical Officer | Sale | 4,399 | $30.52 | $134257.48 |
| 2025-02-10 | SMITH, THOMAS B | EVP and Chief Medical Officer | Sale | 1,498 | $30.52 | $45718.96 |
| 2025-02-10 | KUHLMANN, SHIRLEY R. | EVP and General Counsel | Buy | 40,965 | — | — |
| 2025-02-10 | KUHLMANN, SHIRLEY R. | EVP and General Counsel | Buy | 29,030 | — | — |
Frequently asked questions
Are COLL insiders buying or selling?
Over the transactions on record, COLL insiders have been net sellers, with about $21.34M in stock sold across 61 sales, against 8 open-market purchases.
Does insider selling at COLL mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which COLL insiders are selling the most?
Recent selling is concentrated in a few names. DREYER, SCOTT accounts for the largest share on record, with about $6.31M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.